Middle East Sovereign Fund Boosts Position in Mylan
Posted on 09/03/2015
Mylan NV, a global pharmaceutical company that focuses on generics and some specialty drugs, wants to acquire Perrigo Company plc, another pharmaceutical company. In late August, shareholders of Mylan approved the company’s offer to buy Perrigo. Perrigo is resisting a US$ 36 billion cash-and-stock offer from Mylan. Hedge funds such as Kyle Bass’ Hayman Capital […]
